napsylate


Also found in: Medical.

nap·sy·late

 (năp′sə-lāt′)
n.
A salt of a sulfonic acid of naphthalene, used in the preparation of various pharmaceuticals.

[Alteration of nap(hthalene)sul(fon)ate.]
References in periodicals archive ?
Specifically, propoxyphene napsylate (100 mg), the active opioid ingredient in Darvocet A500(TM), has been shown to produce approximately equivalent analgesia to 60 mg of codeine, the highest prescription strength of that stronger, more addictive opioid.
Food and Drug Administration (FDA) approval of Darvocet A500(TM) (propoxyphene napsylate and acetaminophen) for the treatment of mild to moderate pain.
In the six-month period since their acquisition at the end of March, the Darvon(R) (propoxyphene hydrochloride) and Darvocet-N(R) (propoxyphene napsylate with acetaminophen) product lines have generated $30.
announced today revised financial guidance now that it has successfully completed the acquisition of the United States rights to the Darvon(R) (propoxyphene hydrochloride) and Darvocet N(R) (propoxyphene napsylate with acetaminophen) family of pain products from Eli Lilly and Company through its NeoSan Pharmaceuticals division.
announced today that its NeoSan Pharmaceuticals business unit has entered into an agreement to purchase the United States rights to the Darvon(R) (propoxyphene hydrochloride) and Darvocet N(R) (propoxyphene napsylate with acetaminophen) family of pain products from Eli Lilly and Company .
Xanodyne has nearly a decade-long history as a pain management company with well known brands such as Darvocet-N[R] (propoxyphene napsylate and acetaminophen), Roxicodone[R] (oxycodone hydrochloride) and Oramorph[R] SR (morphine sulfate sustained release).
charged with possession of propoxyphene napsylate with acetaminophen and possession of dicyclomine , continued to July 7.
Darvocet N(R) (propoxyphene napsylate with acetaminophen, Lilly), aaiPharma, Inc.